Protagenic Therapeutics, Inc.\new Basic Shares Outstanding (Weighted Average)
Protagenic Therapeutics, Inc.\new (PTIX) reported Basic Shares Outstanding (Weighted Average) of 1.81 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 1.81M shares, a 51.09% decline year-over-year.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 1.89M shares, a 260.63% increase year-over-year.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 1.93M shares, a 64.14% decline year-over-year.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.85M shares, a 65.72% decline year-over-year.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic for fiscal 2026 was 2.33M shares, a 56.65% decline from fiscal 2025.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic for fiscal 2025 was 5.37M shares.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic for fiscal 2024 was 4.90M shares, a 12.78% increase from fiscal 2023.
- Protagenic Therapeutics, Inc.\new weighted average number of shares outstanding, basic for fiscal 2023 was 4.34M shares, a 0.62% increase from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.81M shares 10-Q · filed 2026-08-19 | 1.85M shares derived: average of 2 quarters · filed 2026-08-19 | 1.88M shares derived: average of 3 quarters · filed 2026-08-19 | 1.87M shares derived: average of 4 quarters · filed 2026-08-19 | |||
| 2026-03-31 | 1.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | 1.91M shares derived: average of 2 quarters · filed 2026-08-14 | 1.89M shares derived: average of 3 quarters · filed 2026-08-14 | 2.33M shares 10-K · filed 2026-08-14 | |||
| 2025-12-31 | 1.93M shares 10-Q · filed 2026-03-09 | 1.89M shares derived: average of 2 quarters · filed 2026-03-09 | 2.48M shares 10-Q · filed 2026-03-09 | 2.00M shares derived: average of 4 quarters · filed 2026-08-19 | |||
| 2025-09-30 | 1.85M shares 10-Q · filed 2025-11-26 | 2.75M shares 10-Q · filed 2025-11-26 | 2.02M shares derived: average of 3 quarters · filed 2026-08-19 | 2.87M shares derived: average of 4 quarters · filed 2026-08-19 | |||
| 2025-06-30 | 3.70M shares 10-Q · filed 2026-08-19 | 2.11M shares derived: average of 2 quarters · filed 2026-08-19 | 3.21M shares derived: average of 3 quarters · filed 2026-08-19 | 3.75M shares derived: average of 4 quarters · filed 2026-08-19 | |||
| 2025-03-31 | 523.18K shares 10-Q · filed 2025-05-13 | 2.96M shares derived: average of 2 quarters · filed 2026-03-09 | 3.77M shares derived: average of 3 quarters · filed 2026-03-09 | 5.37M shares 10-K · filed 2026-08-14 | |||
| 2024-12-31 | 5.40M shares 10-Q · filed 2026-03-09 | 5.40M shares derived: average of 2 quarters · filed 2026-03-09 | 5.40M shares 10-Q · filed 2026-03-09 | 4.90M shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 5.40M shares 10-Q · filed 2025-11-26 | 4.53M shares 10-Q · filed 2024-11-14 | 5.40M shares 10-Q · filed 2025-11-26 | 4.47M shares 10-Q · filed 2024-11-14 | 3.88M shares derived: average of 4 quarters · filed 2025-11-26 | ||
| 2024-06-30 | 5.40M shares 10-QT · filed 2025-09-10 | 4.44M shares 10-Q · filed 2024-08-14 | 4.44M shares 10-Q · filed 2024-08-14 | 3.37M shares derived: average of 3 quarters · filed 2025-09-10 | 3.61M shares derived: average of 4 quarters · filed 2025-09-10 | ||
| 2024-03-31 | 316.80K shares 10-Q · filed 2025-05-13 | 4.44M shares 10-Q · filed 2024-05-15 | 2.36M shares derived: average of 2 quarters · filed 2025-05-13 | 3.01M shares derived: average of 3 quarters · filed 2025-05-13 | 3.34M shares derived: average of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | 4.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 4.36M shares derived: average of 2 quarters · filed 2025-03-31 | 4.35M shares derived: average of 3 quarters · filed 2025-03-31 | 4.34M shares 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 4.33M shares 10-Q · filed 2024-11-14 | 4.33M shares derived: average of 2 quarters · filed 2024-11-14 | 4.33M shares 10-Q · filed 2024-11-14 | 4.33M shares derived: average of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | 4.33M shares 10-Q · filed 2024-08-14 | 4.33M shares 10-Q · filed 2024-08-14 | 4.32M shares derived: average of 3 quarters · filed 2024-08-14 | 4.32M shares derived: average of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | 4.32M shares 10-Q · filed 2024-05-15 | 4.32M shares derived: average of 2 quarters · filed 2024-05-15 | 4.32M shares derived: average of 3 quarters · filed 2024-05-15 | 4.32M shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 4.32M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | 4.32M shares derived: average of 2 quarters · filed 2024-05-14 | 4.32M shares derived: average of 3 quarters · filed 2024-05-14 | 4.32M shares 10-K/A · filed 2024-05-14 | |||
| 2022-09-30 | 4.32M shares 10-Q · filed 2023-11-14 | 17.29M shares 10-Q · filed 2022-11-14 | 4.32M shares derived: average of 2 quarters · filed 2023-11-14 | 4.32M shares 10-Q · filed 2023-11-14 | 17.27M shares 10-Q · filed 2022-11-14 | -3.53M shares derived: average of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | 4.32M shares 10-Q · filed 2023-08-14 | 17.28M shares 10-Q · filed 2022-08-11 | 4.31M shares 10-Q · filed 2023-08-14 | 17.26M shares 10-Q · filed 2022-08-11 | -6.15M shares derived: average of 3 quarters · filed 2023-08-14 | -481.73K shares derived: average of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | 4.31M shares 10-Q · filed 2023-05-15 | 17.23M shares 10-Q · filed 2022-05-13 | -11.38M shares derived: average of 2 quarters · filed 2023-05-15 | -2.08M shares derived: average of 3 quarters · filed 2023-05-15 | 2.06M shares derived: average of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | -27.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -5.28M shares derived: average of 2 quarters · filed 2023-03-31 | 1.31M shares derived: average of 3 quarters · filed 2023-03-31 | 3.69M shares 10-K · filed 2023-03-31 | |||
| 2021-09-30 | 16.52M shares 10-Q · filed 2022-11-14 | 15.50M shares derived: average of 2 quarters · filed 2022-11-14 | 13.94M shares 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | 14.49M shares 10-Q · filed 2022-08-11 | 12.49M shares 10-Q · filed 2022-08-11 | |||||
| 2021-03-31 | 10.52M shares 10-Q · filed 2022-05-13 | ||||||
| 2015-03-31 | 400.00M shares 10-Q · filed 2015-05-11 | 400.00M shares derived: average of 2 quarters · filed 2015-05-11 | 400.00M shares 10-Q · filed 2015-05-11 | 400.00M shares derived: average of 4 quarters · filed 2015-05-11 | |||
| 2014-12-31 | 400.00M shares 10-Q · filed 2015-02-06 | 400.00M shares 10-Q · filed 2015-02-06 | 400.00M shares derived: average of 3 quarters · filed 2015-02-06 | 400.00M shares derived: average of 4 quarters · filed 2015-05-11 | |||
| 2014-09-30 | 400.00M shares 10-Q · filed 2014-11-13 | 400.00M shares derived: average of 2 quarters · filed 2014-11-13 | 400.00M shares derived: average of 3 quarters · filed 2015-05-11 | 400.00M shares derived: average of 4 quarters · filed 2015-05-11 | |||
| 2014-06-30 | 400.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-10-14 | 400.00M shares derived: average of 2 quarters · filed 2015-05-11 | 400.00M shares derived: average of 3 quarters · filed 2015-05-11 | 400.00M shares 10-K · filed 2014-10-14 | |||
| 2014-03-31 | 400.00M shares 10-Q · filed 2015-05-11 | 400.00M shares derived: average of 2 quarters · filed 2015-05-11 | 400.00M shares 10-Q · filed 2015-05-11 | ||||
| 2013-12-31 | 400.00M shares 10-Q · filed 2015-02-06 | 400.00M shares 10-Q · filed 2015-02-06 | |||||
| 2013-09-30 | 400.00M shares 10-Q · filed 2014-11-13 | ||||||
| 2011-09-30 | 6.30M shares 10-Q · filed 2011-11-14 | 6.31M shares derived: average of 2 quarters · filed 2011-11-14 | 6.31M shares 10-Q · filed 2011-11-14 | ||||
| 2011-06-30 | 6.32M shares 10-Q/A · filed 2011-09-07 | 6.31M shares 10-Q/A · filed 2011-09-07 | |||||
| 2010-09-30 | 5.22M shares 10-Q · filed 2011-11-14 | 5.22M shares derived: average of 2 quarters · filed 2011-11-14 | 5.21M shares 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | 5.22M shares 10-Q/A · filed 2011-09-07 | 5.21M shares 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |